Invention Grant
US09250243B2 Drug selection for lung cancer therapy using antibody-based arrays
有权
使用基于抗体的阵列进行肺癌治疗的药物选择
- Patent Title: Drug selection for lung cancer therapy using antibody-based arrays
- Patent Title (中): 使用基于抗体的阵列进行肺癌治疗的药物选择
-
Application No.: US12172100Application Date: 2008-07-11
-
Publication No.: US09250243B2Publication Date: 2016-02-02
- Inventor: Sharat Singh , Jeanne Harvey
- Applicant: Sharat Singh , Jeanne Harvey
- Applicant Address: CH Vevey
- Assignee: NESTEC S.A.
- Current Assignee: NESTEC S.A.
- Current Assignee Address: CH Vevey
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: G01N33/574
- IPC: G01N33/574 ; G01N33/50 ; G01N33/53
Abstract:
The present invention provides compositions and methods for detecting the activation states of components of signal transduction pathways in tumor cells. Information on the activation states of components of signal transduction pathways derived from use of the invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
Public/Granted literature
- US20110275097A9 DRUG SELECTION FOR LUNG CANCER THERAPY USING ANTIBODY-BASED ARRAYS Public/Granted day:2011-11-10
Information query
IPC分类:
